Latest Breaking News On - Rogers mcintyre - Page 7 : comparemela.com

Efficacy of novel drug proven in MDD study

Efficacy of novel drug proven in MDD study
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesRogers mcintyreSanjayj mathewCognition discovery foundationBaylor college of medicineUniversity of torontoExecutive directorHamilton rating scaleHamilton pleasure scaleVice chairBaylor collegeBlackthorn therapeuticsDepression rating scaleSnaith hamilton pleasure scaleAsia pacific

Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder

Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPaull bernsSanjayj mathewRogers mcintyreAsia pacificHelen rubinsteinCognition discovery foundationBaylor college of medicineUniversity of torontoNeumora therapeutics incDrug administrationNew drug applicationDepression rating scaleSnaith hamilton pleasure scaleBaylor collegeBlackthorn therapeutics

A Conversation on the Role of Rapid Acting Therapies in the Management of Major Depressive Disorder

Roger S. McIntyre, M.D., FRCPC introduces a video program where a panel of experts in management of mood disorders discuss the role of rapid acting therapies, specifically GABAA receptor modulators in the management of major depressive disorder; highlighting their mechanism of action, clinical utility, and the on-going research efforts within this arena.

Rogers mcintyreRapid acting therapiesMajor depressive disorderMajor depressive

Ketamine Shows Promise for Hard-to-Treat Depression in New Study

Research this week presents the most robust evidence to date that ketamine is at least as effective as electroconvulsive therapy for patients with treatment-resistant depression who do not have psychosis.

United statesAmit anandRobert freedmanDanielf maixnerRogers mcintyreHarvard medical schoolUniversity of coloradoUniversity of michiganUniversity of torontoCleveland clinic foundationDrug administrationNew england journalMass generalMichigan medicineElectroconvulsive therapyThe new england journal of medicine

Braxia Scientific Corp : Braxia Scientific Reports Q3 2023 Financial Results and Provides Update on Acquisition Under LOI with Irwin Naturals

Braxia Health ketamine treatments up 29% YoY in Q3 2023 and revenue up 50.5% YoYToronto, Ontario (Newsfile Corp. - March 1, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960),

United statesRoger mcintyreDennis riedlRogers mcintyreIrwin naturals incBraxia healthBraxia scientific corpUnited states district courtNewsfile corpExcellence incInternational clinical research servicesHealth canadaCanadian rapid treatment centerIrwin naturalsElectronic document analysisNorth american